The scientist rewriting DNA, and the future of medicine A revolution is underway in gene editing -- and at its forefront is David Liu, an American molecular biologist whose pioneering work is ...

The firm's next-generation sequencing-based test detects single nucleotide variants, insertions, and deletions in 22 genes.

An AI model trained on nearly one million bacterial genomes can predict when and where antibiotic resistance genes are likely ...

Researchers harness the power of the world’s most advanced supercomputers to simulate the inner workings of cellular ...

Vaccine-derived polioviruses were detected in wastewater samples from 5 European countries in late 2024, but no human cases were reported.

Regulus Therapeutics (RGLS) stock soars after positive Phase 1b trial data for the company's lead asset, farabursen against a ...

Here we show a unique and previously unrecognized mechanism of drug action in which Et743 subverts normal nucleotide excision repair (NER) by generating lethal DNA breaks during by transcription ...

Quiver Bioscience (“Quiver”), a discovery technology and therapeutics company advancing programs for the treatment of serious central nervous system (CNS) disorders, announces today a ...

Molecular markers, such as single nucleotide polymorphisms (SNPs) and microsatellites, have been used to study cacao genetics, yet chloroplast genome data remain scarce. Plastid genomes provide ...

Japan's Ono Pharmaceutical is handing over $280 million upfront to acquire Ionis Pharmaceuticals’ phase 2-stage antisense oligonucleotide for a rare type of blood cancer. The RNA-targeted ...